ArticleEBioMedicine2019

Molecular mechanisms underlying mifepristone's agonistic action on ovarian cancer progression.

Donata Ponikwicka-Tyszko et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.